Leyman Barbara
SEC CIK 2028309 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STRO | SUTRO BIOPHARMA, INC. | Chief Business Off | 25.0K | — | — | 2 | 2025-07-08 | 2025-07-08 |
Most active insiders at STRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MATSUI CONNIE | Dir | $40.0K | — |
| 2 | Chow Gregory K. | CFO | $16.0K | — |
| 3 | Gerber Hans-Peter | CSO | $13.6K | — |
| 4 | Pauling David | GC, Chief Admin. Ofcr | $10.0K | — |
| 5 | Chung Jane | CEO, Dir | $10.0K | — |
Leyman Barbara made no open-market trades at STRO in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-26 | 2025-07-08 | STRO | SUTRO BIOPHARMA, INC. | Leyman Barbara | Chief Business Off | M - OptEx | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2025-08-26 | 2025-07-08 | STRO | SUTRO BIOPHARMA, INC. | Leyman Barbara | Chief Business Off | F - Tax | $0.78 | -8,944 | 16.1K | -36% | -$6,976 |
Purchase Sale Sale after option exercise All abbreviations